Chitin and Chitosan Derivatives: Technologies, Applications and Global Markets

Chitin and Chitosan Derivatives: Technologies, Applications and Global Markets

PR Newswire

NEW YORK, July 24, 2017 /PRNewswire/ — Use this report to:
– Analyze and classify products and applications of chitin and chitosan derivatives.
– Discuss the industries that are using the products and study the motivating and restraining factors.

Read the full report: http://www.reportlinker.com/p04806925/Chitin-and-Chitosan-Derivatives-Technologies-Applications-and-Global-Markets.html

– Evaluate the role of chitin and chitosan derivatives in agrochemicals, industrial, biomedicine, pharmaceuticals etc.
– Explore raw materials and key technologies used in the chitin and chitosan derivatives market.

Highlights
– The global chitin and chitosan market should reach $4.2 billion by 2021 from $2.0 billion in 2016 at a compound annual growth rate (CAGR) of 15.4%, from 2016 to 2021.
– The chitosan market should reach $2.1 billion by 2021 from $1.0 billion in 2016 at a CAGR of 16.1%, from 2016 to 2021.
– The glucosamine market should reach $1.6 billion by 2021 from $775 million in 2016 at a CAGR of 15.2%, from 2016 to 2021.

Introduction & Scope

INTRODUCTION

STUDY GOALS AND OBJECTIVES
The objective of the report is to identify the key trends in the global markets for chitin and chitosan derivatives. The report quantifies the worldwide growth potential of chitin and chitosan derivatives over the five-year period from 2016 through 2021. The total market size of chitin and chitosan derivatives with a regional breakdown has been covered in the study. The study focuses on identifying key end users and industries that will affect the major market trends.
The key factors driving the rising demand for chitin and chitosan include their wide range of applications, large number of end-user industries and significant
developments in the research of chitin and chitosan derivatives. The major end-user industries include water treatment, food and beverages, personal care products, agrochemicals, industrial, biomedicine, pharmaceuticals and a number of other industries. The role of chitin and chitosan derivatives in these applications is analyzed thoroughly to identify the key market trends.

REASONS FOR DOING THE STUDY
This BCC Research study is presented to increase the awareness of the applications of chitin and chitosan derivatives. Chitin is the second largest biopolymer after cellulose with a wide range of applications. Chitin is a natural polymer derived from marine crustaceans, shrimps, crabs and other non-animal sources. It is produced through waste products from the seafood processing industry. Recently the demand for chitin and chitosan has increased due to its easy availability and easy production process. Properties such as its nontoxicity, biocompatibility and biodegradability make it ideal for making healthcare products sutures, implants and artificial organs.

It can stimulate defensive mechanism properties in plants, making it ideal for crop protection. Chitin and chitosan derivatives are natural polymers and provide an ecofriendly solution to variety of applications such as water treatment, biomedical, pharmaceuticals, fertilizers and pesticides. Chitin and chitosan derivatives are used in dietary supplements because of their various health benefits. The report analyzes and classifies products and applications of chitin and chitosan derivatives. The report intends to explain the key trends in the industry. It discusses the industries that are using the products and studies the motivating and restraining factors. The report will be a key decision-making tool for the intended audience.

INTENDED AUDIENCE
The report focuses on the use of chitin and chitosan derivatives in industries such as healthcare, pharmaceuticals, food and beverages, personal care products, water treatment and seafood processing. Chitin is produced from waste material from the seafood processing industry, therefore, it helps in waste management too. Chitin and chitosan are environmentally friendly products and increased consumption could help reduce environmental toxins as they are substitutes for the harmful chemicals that are used in water treatment, fertilizers and pesticides. There are vast natural sources of the raw material used to produce chitin and chitosan and only a fraction of that raw material is converted to chitin and chitosan. A number of companies and organizations are performing research and development to increase the utilization of this raw material. The report provides useful information to the industries listed above as well as companies that want to enter the market. As the report also covers the major geographic markets in detail, companies interested in expanding their geographic reach will also find the report useful.

SCOPE OF REPORT
Chitin and chitosan derivatives are naturally occurring polymers with a wide range of applications. Due to the wide availability of the raw material used to obtain chitin and chitosan derivatives, demand for these products has increased recently. To provide a better understanding of the market, the market is segmented on the basis of product and application. Major products included in the report are chitin, chitosan, glucosamine and other derivatives. The application markets covered in the report are healthcare, biotechnology, animal food, agriculture, water treatment, food and beverage and water treatment. The report also covers the subsegments and related markets of the application markets above. The raw materials and key technologies used in the chitin and chitosan derivatives market are also covered at length.

All of the product and application markets are further segmented by geographic region. The major geographic regions covered in the report are North America, South America, Europe, Asia-Pacific and the rest of the world (RoW), which includes Morocco, Egypt, South Africa and other African countries. A country-specific breakdown of the market for chitin and chitosan derivatives is also included in the report. Estimated values used are based on manufacturers’ total revenues. The study covers the global market for chitin and chitosan derivatives and is not limited to the countries included in this report. The selection of the countries to be included in this report was mainly based on the total revenue generated from the sale of chitin and chitosan derivatives. Major countries included in the report are the U.S., Canada, Germany, the U.K., Spain, Italy, France, China, Japan and India.

The competitive landscape of the global market for chitin and chitosan derivatives is discussed and includes profiles of the major companies and their product portfolios. All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors and competitor market shares.

METHODOLOGY
The information and analysis presented in the report are based on extensive first-hand interviews with primary research sources, including executives, product managers and specialists in the market for chitin and chitosan derivatives. Secondary information was obtained from government agencies, business and trade magazines, official websites of key manufacturers and key end users. Some of these sources include companies involved in healthcare, pharmaceutical, water treatment, pesticide and fertilizers, food and beverages, animal feed, personal care products and biotechnology. Annual revenues of major chitin and chitosan derivatives companies, their annual reports and forward-looking statements as well as industry end users were analyzed to derive the size of the market. Key information from published literature was used to conduct interviews with a number of industry participants to validate and obtain expert opinions on current and future trends in the chitin and chitosan derivatives market.

Read the full report: http://www.reportlinker.com/p04806925/Chitin-and-Chitosan-Derivatives-Technologies-Applications-and-Global-Markets.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

http://www.reportlinker.com
 

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/chitin-and-chitosan-derivatives-technologies-applications-and-global-markets-300492936.html

SOURCE Reportlinker

L2 Report Reveals How Indie Brands Are Steering the Future of Digital Marketing Within the Hair Care and Color Category

Logo

L2 Report Reveals How Indie Brands Are Steering the Future of Digital Marketing Within the Hair Care and Color Category

PR Newswire

NEW YORK, July 24, 2017 /PRNewswire/ – Digital benchmarking firm L2 Inc releases its 5th annual Digital IQ Index Report: Hair Care & Color 2017.

L2 Inc.

The L2 report benchmarks the digital performance of 91 Hair Care and Color brands across both Consumer and Professional product segments. The report identifies key digital strategies and best practices for brands to succeed amidst evolving shopping habits and search behaviors of the hair care consumer. The L2 Digital IQ Index methodology examines a brand’s strengths and weaknesses across the four digital dimensions of Site and E-Commerce, Digital Marketing, Social, and Mobile. Index brands are classified as either Genius, Gifted, Average, Challenged, or Feeble.

“Established Hair Care and Color players such as L’Oréal and Garnier continue to prioritize their digital investments, earning the top spots in this year’s Index,” explained Giulia Prati, Associate Director of Beauty Research at L2. “However, brash indie players are challenging heritage brands, who in lieu of large budgets, are rapidly gaining market share and consumer loyalty by taking a mobile-first approach to digital, exploring new growth channels, focusing on savvy social media strategies, and forging unique partnerships.”

Key Findings from L2 Report:

Smarter Search: Just 40 percent of Google Hair Care searches specify a brand, down from 44 percent the year before. Instead, consumers are actively researching products specific to their hair type, gender, ethnicity and by product ingredients, as searches for Tea Tree, Coconut Milk, and Keratin climbed to new heights in June 2017 representing 100, 67, and 54 percent of Indexed Google search volume.

Reimagined Distribution: Ulta leads the way for online shopping when it comes to Salon brands (58 percent), while Target dominates the digital distribution for Consumer brands (80 percent). However, the line between consumer and professional brands continues to blur as 28 percent of Salon brands and 58 percent of consumer brands now distribute on Amazon.

Mobile First: Mobile site optimization has become table stakes for hair care and color brands, with 96 percent of tracked brands having mobile-optimized sites, up from 87 percent last year. Indie brands have been quick to connect with consumers through mobile-first content and features: 29 percent of tracked indie brands offering DTC e-commerce integrate live chat into their mobile experiences, versus only 15 percent of other Index brands.

The report features case studies on brands including but not limited to: Aveda, L’Oréal, Nexxus Olaplex, Ouai, Redken, and Suave.

To access a complete media-only copy of L2’s Intelligence Report: Loyalty 2017, contact

johanna.azis@l2inc.com

About L2
L2 benchmarks the digital performance of over 2,200 brands across 12 industries globally. The L2 Digital IQ Index is the global standard for measuring digital competence. We analyze 1,250 data points to provide brands with actionable, data driven insights on their digital performance.

View original content with multimedia:http://www.prnewswire.com/news-releases/l2-report-reveals-how-indie-brands-are-steering-the-future-of-digital-marketing-within-the-hair-care-and-color-category-300492920.html

SOURCE L2

From Volume to Value: ACOs and Value-based Care Market 2017- Key Insights into Accountable Care, Bundled Payments and Other Value-Based Health Care Delivery Models

Logo

From Volume to Value: ACOs and Value-based Care Market 2017- Key Insights into Accountable Care, Bundled Payments and Other Value-Based Health Care Delivery Models

PR Newswire

DUBLIN, July 24, 2017 /PRNewswire/ —

The “From Volume to Value: ACOs and Value-based Care” report has been added to Research and Markets’ offering.

Logo

The health care marketplace has always been dynamic, but with the rapid rise in alternative payment models in recent years, health care executives must understand the move from volume to value-and the opportunities that are arising from the evolving health care delivery marketplace.

From Volume to Value: ACOs and Value-based Care is a complete overhaul of our original ACO Outlook report first launched in 2014. In this extensive report, we provide key insights into the world of accountable care, bundled payments and other value-based health care delivery models. ACOs and Value-based Care is informed by primary research from November 2016 with Darwin’s ACO Executive Panel, as well as trends gleaned from our earlier ACO leadership surveys.

ACOs and Value-based Care is packed with original research and insights you won’t find anywhere else. See below for a detailed table of contents.

This Report is Designed for Executives in the Following Market Segments:

– Pharma/biotech and medical device market access executives- Integrated health systems, physician groups and ACOs

– Retail and wholesale pharmacy

– DME and medical supplies

– Home health, home care, hospice, and post-acute providers

– Health services researchers

– Payers and other providers

– Private equity and venture capital investors

ACOs and Value-based Care consists of a printed, wire-bound document plus a downloadable .pdf, 310 pages, including a 24-page executive summary and 89 figures and tables. Subscribers will receive periodic updates in .pdf format for one year from the date of purchase.

Purchasers of either a Department or Global Site License will receive a 90-minute, in-person Q&A with Darwin Health CEO John Marchica. Please contact service@darwinhealth.net for more information.

ACOs and Value-based Care is part of a larger syndicated research effort. Partners interested in participating in this ongoing project have the opportunity to get specific questions answered, tailoring the report to their needs. Please contact us if you are interested in diving even deeper into value-based care and alternative payment models.

Key Topics Covered:

Executive Summary

1: Introduction

– Value-based Care Models

– Value-Based Care Defined

2. Medicare ACO Models

– Pioneer Model

– Medicare Shared Savings Program

– Advance Payment ACO Model

– ACO Investment Model

– Next Generation ACO

– Comprehensive ESRD Care (CEC) Model

– Newest Medicare ACO Models

Vermont receives federal approval for statewide all-payer ACO”

3. Other Value-based Care Models

– Medicaid ACOs

– Commercial ACOs

– Employer-led ACOs

– Employer-driven bundles

– Patient-Centered Medical Homes

4. Innovation Center Initiatives: National

– Bundled Payments for Care Improvement (BPCI) Initiative

– Comprehensive Primary Care Initiative (CPC)

– Community-based Care Transitions Program (CCTP)

– FQHC Advanced Primary Care Practice Demonstration

– Independence at Home Demonstration

– Independence at Home: A Success Story

– Home Health Value-based Reimbursement Pilot

– Nursing Home Value-Based Purchasing Demonstration

5. Innovation Center Models: State

6. Innovation Center Models: Local

7. Issue Brief: The Oncology Care Model

8. Issue Brief: The Cardiac Care Bundle

9. Issue Brief: Understanding MACRA

10. Issue Brief: Value-based Contracting in Pharmaceuticals

3: 2016 ACO Executive Survey

1. Research Focus

2. Methodology

3. ACO Characteristics

4. Results

A. 2017 Initiatives

B. Reducing Readmissions

C. Patient Data Management

D. Issues Affecting Cost and Quality

E. Relationships with Suppliers and Providers

F. Relationships with Pharmaceutical Companies

5. Summary

4: Influential ACOs

1. Advocate Health

2. Arizona Care Network

3. Atrius Health

4. Baylor Scott&White Quality Alliance

5. Beacon Health LLC

6. Beth Israel Deaconess Care Organization

7. Carolinas HealthCare System (Triad Health Network)

8. Dartmouth-Hitchcock

9. Memorial Hermann

10. Ochsner Accountable Care Network LLC

11. Optimus Healthcare Partners

12. Partners HealthCare

13. Physician Organization of Michigan

14. UCLA Health ACO

5: Performance

A. Quality

– Medicare ACO Quality Metrics

– MSSP Average Quality Scores, 2013-2015

– Pioneer Average Quality Scores, 2012-2015

– Quality Metrics

1. Patient/Caregiver Experience

2. Preventive Medicine

3. Readmission Rates

4. SNF Admissions

5. Unplanned Admissions for Patients with Diabetes

6. Unplanned Admissions for Patients with Heart Failure

7. Unplanned Admissions for Patients with Multiple Chronic Conditions

8. COPD or Asthma Admissions

9. Heart Failure

10. Meaningful Use

11. Diabetes Composite

12. Overall Quality

B. Financial Performance 2015

C. Aggregate Financial Performance 2015

D. Bundled Payments

6: Implications for Suppliers

1. Pharmacy

2. Pharmaceuticals and Biotechnology

3. Medical Device Providers

4. Durable Medical Equipment

5. Home Health Care

6. Ambulatory Care

7. Long-term Care

8. Other Providers and Suppliers

9: Market Outlook

1. Issues and Opportunities

2. Critical Success Factors

Conclusion

Companies Mentioned

– Advocate Health

– Arizona Care Network

– Atrius Health

– Baylor Scott&White Quality Alliance

– Beacon Health LLC

– Beth Israel Deaconess Care Organization

– Carolinas HealthCare System (Triad Health Network)

– Dartmouth-Hitchcock

– Memorial Hermann

– Ochsner Accountable Care Network LLC

– Optimus Healthcare Partners

– Partners HealthCare

– Physician Organization of Michigan

– UCLA Health ACO

For more information about this report visit

https://www.researchandmarkets.com/research/t7mpdr/from_volume_to

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

View original content:http://www.prnewswire.com/news-releases/from-volume-to-value-acos-and-value-based-care-market-2017–key-insights-into-accountable-care-bundled-payments-and-other-value-based-health-care-delivery-models-300492878.html

SOURCE Research and Markets